US20030072805A1 - Microgel and external compositions containing the same - Google Patents

Microgel and external compositions containing the same Download PDF

Info

Publication number
US20030072805A1
US20030072805A1 US09936317 US93631701A US2003072805A1 US 20030072805 A1 US20030072805 A1 US 20030072805A1 US 09936317 US09936317 US 09936317 US 93631701 A US93631701 A US 93631701A US 2003072805 A1 US2003072805 A1 US 2003072805A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
composition
ingredient
gel
viscosity
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09936317
Inventor
Kazuyuki Miyazawa
Isamu Kaneda
Toshio Yanaki
Tadashi Nakamura
Masatoshi Ochiai
Tomoyuki Kawasoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/02Cosmetics or similar toilet preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/02Cosmetics or similar toilet preparations characterised by special physical form
    • A61K8/0212Face masks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/30Cosmetics or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toilet preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/30Cosmetics or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/30Cosmetics or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/72Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/72Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/733Alginic acid; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/72Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/72Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/72Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/72Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/96Cosmetics or similar toilet preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toilet preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/96Cosmetics or similar toilet preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toilet preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toilet preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/982Reproductive organs; Embryos, Eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/04Alginic acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/12Agar or agar-agar, i.e. mixture of agarose and agaropectin; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00Compositions of proteins; Compositions of derivatives thereof
    • C08L89/04Products derived from waste materials, e.g. horn, hoof or hair
    • C08L89/06Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/412Microsized, i.e. having sizes between 0.1 and 100 microns
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/06Preparations for styling the hair, e.g. by temporary shaping or colouring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/06Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A61Q5/065Preparations for temporary colouring the hair, e.g. direct dyes

Abstract

The present invention provides a microgel having a mean particle size of 0.1-1,000 μm, the microgel being produced from a gel which is formed by use of a hydrophilic compound capable of forming a gel. An external composition containing the microgel provides an excellent sensation during use; i.e., the composition provides neither sticky sensation during use nor frictional sensation. Furthermore, even when a large amount of a pharmaceutical ingredient, such as a whitening ingredient, or a salt is incorporated into the composition, the viscosity of the composition is not lowered, and the composition exhibits excellent viscosity increasing property. In addition, the composition exhibits long-term stability, without inviting separation of water.

Description

    TECHNICAL FIELD
  • [0001]
    The present invention relates to a viscosity control agent which is used mainly in the fields of, for example, cosmetic compositions and drugs. The present invention also relates to external compositions, such as cosmetic compositions, comprising the viscosity control agent.
  • BACKGROUND ART
  • [0002]
    Conventionally known methods for increasing the viscosity of an external composition include a method for incorporating into the composition a viscosity control agent or a thickening agent; for example, a polysaccharide such as xanthan gum, a hydrophilic synthetic polymer such as a polyacrylic acid, or a clay mineral such as bentonite.
  • [0003]
    When a polysaccharide such as xanthan gum is incorporated, as a viscosity control agent, into an external composition, the composition involves problems in terms of sensation during use; for example, the composition provides a sticky sensation during use, although such a polysaccharide exhibits excellent stability in the composition into which a pharmaceutical ingredient or a salt is incorporated. When a hydrophilic synthetic polymer such as polyacrylic acid is incorporated into an external composition, the composition provides good sensation during use; i.e., the composition provides no sticky sensation during use, but provides a refreshing sensation during use. However, such a hydrophilic synthetic polymer has low resistance to a salt or an ionic substance. Therefore, when a large amount of a salt or a pharmaceutical ingredient such as a whitening ingredient; for example, L-ascorbic acid (i.e., vitamin C) or arbutin, is incorporated into the composition, the composition involves problems including lowering of the viscosity of the composition. When a clay mineral such as bentonite is incorporated, as a viscosity control agent, into an external composition, the composition involves problems in terms of sensation during use; for example, the composition provides a frictional sensation during use.
  • [0004]
    An object of the present invention is to provide a new type of viscosity control agent which, when incorporated as an ingredient into an external composition, imparts the composition with excellent sensation during use; i.e., free of sticky sensation or frictional sensation. Furthermore, even when a large amount of a salt or a pharmaceutical ingredient such as a whitening ingredient is incorporated into the composition, the viscosity of the composition is not lowered, the composition exhibits long-term stability, and separation of water does not occur. Another object of the present invention is to provide an external composition comprising the viscosity control agent.
  • DISCLOSURE OF THE INVENTION
  • [0005]
    The present inventors have performed extensive studies in order to attain the aforementioned objects, and have found that, when a compound capable of forming a gel, such as agar which is conventionally used as a gelation agent, is formed into a gel, the resultant gel is pulverized into a microgel, and then the resultant microgel is incorporated, as a viscosity control agent, into an external composition, the composition provides no sticky sensation during use, and the viscosity of the composition is not lowered even when a large amount of pharmaceutical ingredient such as a whitening ingredient or large amounts of various salts are incorporated into the composition. The present invention has been accomplished on the basis of this finding.
  • [0006]
    Accordingly, the present invention provides a microgel having a mean particle size of 0.1-1,000 μm, the microgel being produced from a gel which is formed by use of a hydrophilic compound capable of forming a gel (hereinafter the microgel may be referred to as “the present microgel”).
  • [0007]
    The present microgel may be produced through a process comprising dissolving, in an aqueous solvent, a hydrophilic compound capable of forming a gel; forming a gel; and pulverizing the gel into a microgel having a mean particle size of 0.1-1,000 μm (hereinafter the process may be referred to as “the present production process”).
  • [0008]
    The present invention also provides an external composition comprising the present microgel (hereinafter the composition may be referred to as “the present external composition”). In the external composition of the present invention, a salt or a pharmaceutical ingredient such as a whitening ingredient may be incorporated intentionally.
  • [0009]
    As used herein, the term “external composition” refers to a composition which is applied onto the skin (including the scalp and hair) . The composition can be used to prepare, for example, cosmetic compositions, hair-dyes, external drugs, and external quasi-drugs.
  • BEST MODE FOR CARRYING OUT THE INVENTION
  • [0010]
    Embodiments of the present invention will next be described.
  • [0011]
    No particular limitation is imposed on the hydrophilic compound capable of forming a gel which is used for producing the present microgel, so long as the compound is a water-soluble soluble compound capable of forming a gel and can be incorporated into an external composition. Specific examples of the hydrophilic compound include hydrophilic proteins capable of forming a gel, such as gelatin and collagen; and hydrophilic polysaccharides such as agar, curdlan, scleroglucan, schizophyllan, gellan gum, alginic acid, carrageenan, mannan, pectin, and hyaluronic acid. Of these, gelatin, agar, curdlan, gellan gum, alginic acid, or carrageenan is particularly preferred, since such a compound is not easily affected by a salt or an ionic substance in the composition, and enables to provide a stable gel. One or more of these gel-formable hydrophilic compounds may be used.
  • [0012]
    The present microgel may be produced through, for example, the below-described process (i.e., the present production process).
  • [0013]
    Firstly, any of the aforementioned hydrophilic compounds capable of forming a gel is dissolved in an aqueous solvent such as water, and is allowed to form a gel. The hydrophilic compound may be dissolved in an aqueous solvent through a customary method; for example, through mixing or heating. Gelation (solidification) is preferably carried out by stopping heating of the resultant mixture after dissolving, and then allowing the mixture to stand still until the temperature of the mixture becomes lower than the gelation temperature (solidification temperature).
  • [0014]
    The aqueous solvent is not particularly limited, so long as the solvent can be incorporated into an external composition. Examples of the aqueous solvent include water; glycols such as 1,3-butylene glycol and propylene glycol; and lower alcohols such as ethanol and propanol. One or more of such aqueous solvents may be used. Water or a mixture of water and another aqueous solvent is preferably used.
  • [0015]
    The aqueous solvent may contain a water-soluble ingredient other than the aqueous solvent, which ingredient can be incorporated into an external composition. Specific examples of the water-soluble ingredient include, but are not limited to, chelating agents such as metaphosphates and edetates; pH-adjusting agents; preservatives; water-soluble pharmaceutical ingredients; and salts.
  • [0016]
    The gel strength of the aforementioned gel is not particularly limited, so long as the gel can maintain its shape and the gel can be subjected to the subsequent procedure to thereby form a microgel. In the present invention, a gel having a very high gel strength; for example, a gel having a high jelly strength (as measured according to the official method of Japanese Association of Agar) of up to 1,000 g/cm2 or thereabouts, can be used. Meanwhile, a gel having a very low jelly strength (i.e., a jelly strength of 30 g/cm2 or thereabouts) can also be formed into a microgel. From the viewpoint of enhancement of sensation during use, a gel having a jelly strength of 100 g/cm2 or thereabouts is preferred.
  • [0017]
    In order to vary sensation during use of the present external composition, a viscosity increasing compound incapable of forming a gel may be incorporated into the present external composition in addition to the aforementioned hydrophilic compound capable of forming a gel. Examples of the viscosity increasing compound incapable of forming a gel include hydrophilic viscosity increasing compounds including hydrophilic synthetic polymers such as polyacrylic acid, polyethylene glycol, polyacrylamide, polyalkylacrylamide/polyacrylamide copolymers, carboxymethyl cellulose, cationized cellulose, and pluronic; hydrophilic naturally-occurring polymers such as xanthan gum, succinoglycan, guar gum, and locust bean gum; and hydrophilic clay minerals such as laponite, bentonite, and smectite. When such a hydrophilic viscosity increasing compound incapable of forming a gel is used in combination with the hydrophilic compound capable of forming a gel, the gel strength of the resultant gel can be arbitrarily regulated. When the amount of the viscosity increasing compound incapable of forming a gel in the resultant gel is increased, the gel strength is lowered. The viscosity increasing compound incapable of forming a gel is particularly preferably xanthan gum, succinoglycan, polyacrylic acid, polyethylene glycol, polyacrylamide, or a polyalkylacrylamide/polyacrylamide copolymer. A salt of the viscosity increasing compound is also preferably used. One or more of the viscosity increasing compounds incapable of forming a gel may be used.
  • [0018]
    The incorporation amount of the hydrophilic viscosity increasing compound incapable of forming a gel varies with intended use of the resultant viscosity control agent. The viscosity increasing compound incapable of forming a gel may be incorporated in an amount of about 1-100 mass % based upon the hydrophilic compound capable of forming a gel.
  • [0019]
    Subsequently, the gel formed as described above is pulverized (crushed) by means of, for example, a homogenizer, a high speed mixer, or a mechanical stirrer, to thereby obtain a desired microgel. The mean particles size of the microgel is preferably about 0.1-1,000 μm, more preferably about 1-300 μm, much more preferably about 10-200 μm. The degree of pulverization of the gel may be regulated in accordance with use of the microgel. When the microgel is required to have a smooth sensation during use, the gel is sufficiently pulverized through high-speed stirring, to thereby obtain a microgel having a very small particle size. When an intrinsic tactile sensation of the microgel is required, the degree of pulverization of the gel is decreased through low-speed or brief stirring, to thereby obtain a microgel having a slightly large particle size.
  • [0020]
    The viscosity of the thus-obtained microgel varies in accordance with use or need of the microgel. For example, when agar is used as the hydrophilic compound capable of forming a gel, the viscosity of the resultant microgel (agar content: about 0.5-2%) is preferably about 2,000-1,000,000 mPa·s, the viscosity being measured by use of a B-type viscometer (revolution number: 0.6 rpm, at 25° C.).
  • [0021]
    When the microgel produced by the present invention is incorporated, as a viscosity control agent, into an external composition, improvement of sensation during use of the composition (i.e., suppression of a sticky sensation during use) can be attained. Even when a pharmaceutical ingredient, salt, etc. is incorporated into the external composition in a large amount; for example, in an amount of about 20 mass % of the total of the composition, the viscosity of the composition is not lowered; i.e., the viscosity of the composition can be maintained. Furthermore, the composition exhibits long-term stability, and separation of water does not occur. The amount of a pharmaceutical ingredient or a salt incorporated into the composition is preferably about 0.1 mass % or more of the total of the composition, in order to obtain the intended effects of incorporation of such an ingredient.
  • [0022]
    The present external composition may contain a water-soluble or oil-soluble pharmaceutical ingredient or salt.
  • [0023]
    A pharmaceutical ingredient is incorporated into the external composition in order to impart effective pharmaceutical activity to the composition. Most pharmaceutical ingredients have a variety of active groups, and assume a salt form. Therefore, when a large amount of such a pharmaceutical ingredient is incorporated into the composition, the stability of a composition may be impaired. Examples of the pharmaceutical ingredient which may be incorporated into the composition include vitamins, anti-inflammatory agents, antibacterial agents, and whitening ingredients. Specific examples of the pharmaceutical ingredient include vitamins and derivatives thereof, such as vitamin B, vitamin P, water-soluble vitamin A, and water-soluble vitamin D; pantothenyl ethyl ether; calcium pantothenate; glycyrrhizic acid; glycyrrhizinates; glycyrrhetic acid; glycyrrhetinates; royal jelly; polyphenol; nicotinic acid and derivatives thereof (e.g., nicotinamide); resorcin; sulfur; salicylic acid and derivative thereof; urea; xylitol; trehalose; and caffeine. One or more of the pharmaceutical ingredients may be incorporated into the present external composition.
  • [0024]
    Preferred examples of the whitening ingredient include L-ascorbic acid and derivatives thereof; arbutin; glutathione; tranexamic acid and derivatives thereof; placenta extract; and vegetable extracts exhibiting whitening effects (e.g., chamomile extract, Scutellaria root extract, and Saxifraga extract).
  • [0025]
    L-ascorbic acid is generally called “vitamin C,” exhibits cell respiration effects, enzyme activation effects, and collagen formation effects, due to its strong reducing effects, and exhibits melanin-reducing effects. Examples of L-ascorbic acid derivatives include L-ascorbic acid monoalkyl esters such as L-ascorbyl monostearate, L-ascorbyl monopalmitate, and L-ascorbyl monooleate; L-ascorbic acid monoesters such as L-ascorbyl monophosphate and L-ascorbyl-2-sulfate; L-ascorbic acid dialkyl esters such as L-ascorbyl distearate, L-ascorbyl dipalmitate, and L-ascorbyl dioleate; L-ascorbic acid diesters such as L-ascorbyl diphosphate; L-ascorbic acid trialkyl esters such as L-ascorbyl tristearate, L-ascorbyl tripalmitate, and L-ascorbyl trioleate; ascorbic acid triesters such as L-ascorbyl triphosphate; L-ascorbic acid glucoside such as L-ascorbic acid 2-glucoside; and salts thereof. of the L-ascorbic acid and derivatives thereof, L-ascorbic acid, L-ascorbyl phosphate, L-ascorbyl-2-sulfate, L-ascorbic acid 2-glucoside, or a salt thereof is preferably used.
  • [0026]
    Examples of tranexamic acid derivatives include dimers of tranexamic acid (e.g., trans-4-(trans-aminomethylcyclohexanecarbonyl) aminomethylcyclohexanecarboxylic acid hydrochloride); esters of tranexamic acid and hydroquinone (e.g., 4′-hydroxyphenyl trans-4-aminomethylcyclohexanecarboxylate); esters of tranexamic acid and gentisic acid (e.g., 2-(trans-4-aminomethylcyclohexylcarbonyloxy)-5-hydroxybenzoic acid and salts thereof); and amides of tranexamic acid (e.g., trans-4-aminomethylcyclohexanecarboxylic acid methylamide and salts thereof, trans-4-(P-methoxybenzoyl) aminomethylcyclohexanecarboxylic acid and salts thereof, and trans-4-guanidinomethylcyclohexanecarboxylic acid and salts thereof).
  • [0027]
    Similar to the case of other pharmaceutical ingredients, one or more of the whitening ingredients may be used.
  • [0028]
    The amount of the whitening ingredient incorporated into the present external composition is preferably about 0.1-20 mass %, more preferably about 0.5-5 mass %, of the total of the composition.
  • [0029]
    Examples of salts include a variety of pharmaceutically acceptable organic acid salts, amino acid salts, and inorganic salts. Examples of the organic acid salts include hydrochlorides, metallic salts (e.g., sodium salts and potassium salts), and amine salts of organic acids such as citric acid, lactic acid, oxalic acid, and sulfonic acid. Examples of the amino acid salts include hydrochlorides, metallic salts (e.g., sodium salts and potassium salts), and amine salts of amino acids such as glycine, alanine, proline, lysine, aspartic acid, and glutamic acid. Examples of inorganic salts include sodium salts, potassium salts, magnesium salts, calcium salts, carbonates, phosphates, nitrates, borates, sulfates, sulfites, and halogen compounds (e.g., sodium chloride and potassium chloride).
  • [0030]
    The present external composition exhibits excellent resistance to a salt. Therefore, even when a large amount of the aforementioned salt or a salt of the aforementioned pharmaceutical ingredient is incorporated into the composition, the stability of the composition is not impaired, and the composition provides an excellent sensation during use as described above.
  • [0031]
    Conventionally, a compound capable of forming a gel, such as agar, carrageenan, curdlan, or gelatin, has been used as a viscosity control agent. In this case, such a compound is heated and dissolved in an external composition, and the resultant mixture is gradually cooled under stirring, to thereby obtain a viscous composition without solidification (gelation) of the compound (e.g., Japanese Patent Application Laid-Open (kokai) No. 11-209262). However, when the external composition containing the compound capable of forming a gel is gradually cooled under stirring as described in the conventional method, to thereby increase the viscosity of the composition, the degree of increase in the viscosity of the composition is limited. Particularly when a pharmaceutical ingredient or a salt is incorporated into the external composition, the viscosity of the composition is prone to decrease.
  • [0032]
    In contrast, in the present invention, after such a compound capable of forming a gel is subjected to complete gelation (solidification), the gelled compound is pulverized into a microgel, and the resultant microgel is used as a viscosity control agent. The present microgel obtained as described above differs from a polysaccharide viscosity control agent or a synthetic polymer viscosity control agent which is conventionally used in an external composition such as a cosmetic composition, in that the present microgel exerts the viscosity increasing effect not through entanglement of molecules but through friction of the microgel particles yielded from pulverization of the gel. Therefore, the present microgel does not exhibit spinnability that is unique to polymer solutions, and an external composition containing the microgel provides a very refreshing sensation during use. Also, as contrasted to polymer solutions, which in some cases are affected by a pharmaceutical ingredient or salt incorporated therein to thereby lower the viscosity and impose limitations on incorporation of the pharmaceutical ingredient or salt, the present invention is free from such problems, permitting a variety of external compositions, including cosmetic compositions, to be formulated.
  • [0033]
    In the present invention, when a water-soluble pharmaceutical ingredient or salt is used, after the aforementioned hydrophilic ingredient capable of forming a gel is dissolved in an aqueous solvent, the resultant mixture is allowed to stand and cool, for example, to thereby form a gel, and subsequently, a microgel obtained by pulverizing the resultant gel may be mixed with the pharmaceutical ingredient or salt. Alternatively, after the aforementioned hydrophilic ingredient and the pharmaceutical ingredient or salt are dissolved in an aqueous solvent, the resultant mixture is allowed to stand and cool, for example, to thereby form a gel, and subsequently the resultant gel may be pulverized into a microgel.
  • [0034]
    When an oil-soluble pharmaceutical ingredient or salt is used, after the aforementioned hydrophilic ingredient capable of forming a gel is dissolved in an aqueous solvent, the resultant mixture is allowed to stand and cool, for example, to thereby form a gel, and subsequently, the resultant gel may be pulverized into a microgel. Separately, the oil-soluble pharmaceutical ingredient or salt and another oil ingredient are preferably preliminarily emulsified in an aqueous system, and the resultant emulsion is mixed with the above-obtained microgel, and the resultant mixture is emulsified.
  • [0035]
    The present external composition containing the present microgel may appropriately contain an ingredient which is generally incorporated into an external composition such as a cosmetic composition, such as a humectant, a preservative, powder, a colorant, a perfume, or a pH-adjusting agent, so long as the ingredient does not impede the purposes and the effects of the present invention.
  • [0036]
    The present microgel may be incorporated into an aqueous external composition, or, similar to the case of a usual polymer viscosity control agent, may be incorporated into an emulsified external composition such as a milky lotion or a cream. The present microgel may be incorporated into an external composition even when the product form of the composition is a hair-setting agent, a hair cream, a body-care product, or hair dye. For example, when the present microgel is incorporated into an acidic hair dye, the stability, the adhesive property, and the usability of the hair dye can be enhanced. In addition, the present microgel per se can be used as a gel-type external composition.
  • EXAMPLES
  • [0037]
    The present invention will next be described in more detail by way of Examples, which should not be construed as limiting the invention thereto.
  • Examples 1 Through 10 and Comparative Examples 1 Through 4
  • [0038]
    External compositions containing ingredients shown in the below-described Tables 1 (1-1 and 1-2) and 2 (2-1 and 2-2) were prepared as follows.
  • [0039]
    Examples 1 through 10: A hydrophilic compound capable of forming a gel and a viscosity increasing compound incapable of forming a gel were added to water, mixed, heated to 90° C., dissolved, and then allowed to stand at room temperature, to thereby form a gel. Subsequently, the gel was pulverized with a homogenizer, to thereby yield a microgel having a mean particle size of 100 μm. The microgel was mixed with the remaining ingredients, and the resultant mixture was stirred, to thereby yield the external compositions of Examples 1 through 10.
  • [0040]
    Comparative Examples 1 through 4: The ingredients were mixed, and then allowed to stand for 12 hours at room temperature, to thereby yield external compositions of Comparative Examples 1 through 4.
  • [0041]
    On the basis of the below-described evaluation criteria, the external composition (sample) of each of Examples 1 through 10 and Comparative Examples 1 through 4 was evaluated in terms of viscosity increasing effect, sensation during use (no sticky sensation during use), whitening effect, and long-term stability. The results are also shown in Tables 1 and 2. “Sodium polyacrylate” shown in Tables 1 and 2 was prepared by neutralizing “Hiviswako 105” (product of Wako Pure Chemical Industries, Ltd.) with an aqueous solution of sodium hydroxide and adjusting pH of the resultant solution to 7.
  • Viscosity Increasing Property
  • [0042]
    The viscosity of the above-obtained sample was measured by use of a B-type viscometer (number of revolution: 0.6 rpm, at 25° C.), to thereby evaluate the viscosity increasing property of the sample.
  • [0043]
    (Evaluation)
  • [0044]
    A: very excellent viscosity increasing property (viscosity: 50,000 mPa·s or more)
  • [0045]
    B: excellent viscosity increasing property (viscosity: 5,000 to 50,000 mPa·s)
  • [0046]
    C: poor viscosity increasing property (viscosity: 500 to 5,000 mPa·s)
  • [0047]
    D: no viscosity increasing property (viscosity: less than 500 mPa·s)
  • Sensation During Use (No Sticky Sensation During Use)
  • [0048]
    Each sample was actually used by 20 female panelists, and sensation during use of the sample was evaluated on the basis of the following criteria.
  • [0049]
    (Evaluation)
  • [0050]
    A: 18 or more of the panelists reported that the sample provided no sticky sensation during use but a refreshing sensation during use
  • [0051]
    B: 15 to 17 of the panelists reported that the sample provided no sticky sensation during use but a refreshing sensation during use
  • [0052]
    C: 6 to 14 of the panelists reported that the sample provided no sticky sensation during use but a refreshing sensation during use
  • [0053]
    D: 5 or fewer of the panelists reported that the sample provided no sticky sensation during use but a refreshing sensation during use.
  • Whitening effect
  • [0054]
    Each sample was used by 20 female panelists consecutively for two weeks, and the whitening effect of the sample was evaluated on the basis of the following criteria.
  • [0055]
    (Evaluation)
  • [0056]
    A: 18 or more of the panelists reported that the sample exhibited excellent whitening effect
  • [0057]
    B: 15 to 17 of the panelists reported that the sample exhibited excellent whitening effect
  • [0058]
    C: 6 to 14 of the panelists reported that the sample exhibited excellent whitening effect
  • [0059]
    D: 5 or fewer of the panelists reported that the sample exhibited excellent whitening effect.
  • Long-Term Stability (No Separation of Water)
  • [0060]
    After the sample was stored at 40° C. for one month, the degree of separation of water was visually observed, and the long-term stability of the sample was evaluated on the basis of the following criteria.
  • [0061]
    (Evaluation)
  • [0062]
    A: no separation of water was observed
  • [0063]
    B: little separation of water was observed
  • [0064]
    C: slight oozing of water was observed
  • [0065]
    D: oozing of water was observed.
    TABLE 1-1
    Ex. 1 Ex. 2 Ex. 3 Ex. 4 Ex. 5 Ex. 6 Ex. 7
    Amount (mass %)
    Agar 1.0 2.0 1.0 1.0
    Carrageenan 1.5
    Curdlan 3.0
    Gelatin 3.0
    Gellan gum
    Alginic acid
    Xanthan gum 0.1 0.1 0.1
    Succinoglycan 0.1 0.2
    Sodium polyacrylate 0.1
    Polyethylene glycol
    (M.W. = 20,000)
    Polyacrylamide 0.1
    (M.W. = 1,000,000)
    Polyalkylcrylamide/
    Polyacrylamide
    copolymer
    (M.W. = 500,000)
    Arbutin 3.0 3.0
  • [0066]
    [0066]
    TABLE 1-2
    Ex. 1 Ex. 2. Ex. 3 Ex. 4 Ex. 5 Ex. 6 Ex. 7
    Amount (mass %)
    L-Ascorbic acid 0.2 2.0
    L-Ascorbic acid 2.0 2.0
    2-glucoside
    Magnesium L- 3.0
    ascorbyl phosphate
    Gultathione 0.1 0.1 0.2
    Tranexamic acid 0.3 0.5
    Placenta extract 0.1
    Chamomile extract 0.1
    CaCl2
    Glycerin 5.0 5.0 5.0 5.0 5.0 5.0 5.0
    Purified water Balance Balance Balance Balance Balance Balance Balance
    Preparation method*)  (1)  (1)  (1)  (1)  (1)  (1)  (1)
    Viscosity-increasing property A A A A A A A
    (viscosity/mPa · s) × 103 (120) (395) (135) (205) (65) (120) (135)
    Sensation during use A A A A A A A
    Whitening effect A A A B A A A
    Long-term stability A A A A A A A
  • [0067]
    [0067]
    TABLE 2-1
    Comp. Comp. Comp. Comp.
    Ex. 8 Ex. 9 Ex. 10 Ex. 1 Ex. 2 Ex. 3 Ex. 4
    Amount (mass %)
    Agar 1.0
    Carrageenan
    Curdlan
    Gelatin
    Gellan gum 0.5
    Alginic acid 2.0
    Xanthan gum 0.2 0.2 0.5 1.0
    Succinoglycan 0.1
    Sodium polyacrylate 0.25 0.5
    Polyethylene glycol 0.2
    (M.W. = 20,000)
    Polyacrylamide
    (M.W. = 1,000,000)
    Polyalkylacrylamide/ 0.1
    polyacrylamide copolymer
    (M.W. = 500,000)
    Arbutin 3.0 3.0
  • [0068]
    [0068]
    TABLE 2-2
    Comp. Comp. Comp. Comp.
    Ex. 8 Ex. 9 Ex. 10 Ex. 1 Ex. 2 Ex. 3 Ex. 4
    Amount (mass %)
    L-Ascorbic acid 0.2
    L-Ascorbic acid 2-glucoside 2.0 2.0 2.0
    Magnesium L-ascorbyl phosphate 3.0 3.0
    Gultathione 0.1 0.1
    Tranexamic acid 0.1
    Placenta extract 0.1 0.1
    Chamomile extract 0.2 0.1
    CaCl2 0.2
    Glycerin 5.0 5.0 5.0 5.0 5.0 5.0 5.0
    Purified water Balance Balance Balance Balance Balance Balance Balance
    Preparation method*)  (1)  (1)  (1)   (2)   (2)  (2)  (2)
    Viscosity-increasing property A A A D D B B
    (viscosity/mPa · s) × 103 (125) (50) (115) (0.25) (0.35) (15) (25)
    Sensation during use A A A D D
    Whithening effect A A A A A
    Long-term stability A A A A A
  • [0069]
    As is apparent from the results shown in Tables 1 and 2, even when the present external composition containing the present microgel contains a large amount of a whitening ingredient, the viscosity of the composition is not lowered. In addition, the present external composition exhibits excellent viscosity increasing property, provides good sensation during use; i.e., provides no sticky sensation during use, and exhibits excellent whitening effect and long-term stability.
  • Examples 11 Through 24 and Comparative Examples 5 Through 11
  • [0070]
    External compositions containing ingredients shown in the below-described Table 3 (3-1 and 3-2) through Table 5 (5-1 and 5-2) were prepared.
  • [0071]
    Specifically, an external composition of each of Examples 11 through 24 was prepared in manner similar to that of the external composition of each of Examples 1 through 10, and an external composition of each of Comparative Examples 5 through 11 was prepared in manner similar to that of the external composition of each of Comparative Examples 1 through 4.
  • [0072]
    The external composition of each of Examples 11 through 24 and Comparative Examples 5 through 11 was evaluated in terms of viscosity increasing effect, sensation during use (no sticky sensation during use), and long-term stability, on the basis of the above-described evaluation criteria. The results are shown in Tables 3 through 5. “Sodium polyacrylate” shown in Tables 3 through 5 was prepared by neutralizing “Hiviswako 105” (product of Wako Pure Chemical Industries, Ltd.) with an aqueous solution of sodium hydroxide and adjusting pH of the resultant solution to 7.
    TABLE 3-1
    Ex. 11 Ex. 12 Ex. 13 Ex. 14 Ex. 15 Ex. 16 Ex. 17
    Amount (mass %)
    Agar 1.0 2.0
    Carrageenan 1.5
    Curdlan 3.0
    Gelatin 3.0
    Gellan gum 1.0
    Alginic acid 2.0
    Xanthan gum 0.1 0.1 0.1 0.2 0.3
    Succinoglycan 0.2 0.1
    Sodium polyacrylate
    Polyethylene glycol
    (M.W. = 20,000)
    Polyacrylamide
    (M.W. = 1,000,000)
    Polyalkylacrylamide/
    polyacrylamide copolymer
    (M.W. = 500,000)
  • [0073]
    [0073]
    TABLE 3-2
    Ex. 11 Ex. 12 Ex. 13 Ex. 14 Ex. 15 Ex. 16 Ex. 17
    Amount (mass %)
    NaCl 2.0 2.0 2.0 2.0 2.0
    CaCl2 0.5 0.5
    Glycine 2.0 2.0
    Glycerin 5.0 5.0 5.0 5.0 5.0 5.0 5.0
    Purified water Balance Balance Balance Balance Balance Balance Balance
    Preparation method*)  (1)  (1)  (1)  (1)  (1)  (1)  (1)
    Viscosity-increasing property A A A A A A A
    viscosity/mPa · s) × 103 (115) (395) (135) (205) (60) (75) (120)
    Sensation during use A A A A A A A
    Long-term stability A A A A A B B
  • [0074]
    [0074]
    TABLE 4-1
    Ex. 18 Ex. 19 Ex. 20 Ex. 21 Ex. 22 Ex. 23 Ex. 24
    Amount (mass %)
    Agar 2.0 2.0 2.0 2.0 2.0 2.0 2.0
    Carrageenan
    Curdlan
    Gelatin
    Gellan gum
    Alginic acid
    Xanthan gum 0.1 0.1 0.1
    Succinoglycan
    Sodium polyacrylate 0.1 0.1
    Polyethylene glycol 1.0
    (M.W. = 20,000)
    Polyacrylamide 0.3 0.1
    (M.W. = 1,000,000)
    Polyalkylacrylamide/ 0.3 0.1
    polyacrylamide copolymer
    (M.W. = 500,000)
  • [0075]
    [0075]
    TABLE 4-2
    Ex. 18 Ex. 19 Ex. 20 Ex. 21 Ex. 22 Ex. 23 Ex. 24
    Amount (mass %)
    Nacl 5.0 5.0 2.0 5.0 5.0 5.0 5.0
    CaCl2
    Glycine
    Glycerin 5.0 5.0 5.0 5.0 5.0 5.0 5.0
    Purified water Balance Balance Balance Balance Balance Balance Balance
    Preparation method*)  (1)  (1)  (1)  (1)  (1)  (1)  (1)
    Viscosity-increasing property A A A A A A A
    viscosity/mPa · s) × 103 (400) (350) (385) (385) (380) (375) (385)
    Sensation during use A A A A A A A
    Long-term stability A A A A A A A
  • [0076]
    [0076]
    TABLE 5-1
    Comp. Comp. Comp. Comp. Comp. Comp. Comp.
    Ex. 5 Ex. 6 Ex. 7 Ex. 8 Ex. 9 Ex. 10 Ex. 11
    Amount (mass %)
    Agar
    Carrgeenan
    Curdlan
    Gelatin
    Gellan gum
    Alginic acid
    Xanthan gum 0.5 1.0
    Succinoglycan
    Sodium polyacrylate 0.25 0.5
    Polyethylene glycol 1.0
    (M.W. = 20,000)
    Polyacrylamide 0.3
    (M.W. = 1,000,000)
    Polyalkylacrylamide/ 0.3
    polyacrylamide copolymer
    (M.W. = 500,000)
  • [0077]
    [0077]
    TABLE 5-2
    Comp. Comp. Comp. Comp. Comp. Comp. Comp.
    Ex. 5 Ex. 6 Ex. 7 Ex. 8 Ex. 9 Ex. 10 Ex. 11
    Amount (mass %)
    NaCl 2.0 2.0 2.0 2.0
    CaCl2
    Glycine 2.0 2.0 2.0
    Glycerin 5.0 5.0 5.0 5.0
    Purified water Balance Balance Balance Balance Balance Balance Balance
    Preparation method*)   (2)   (2)  (2)  (2)   (2)  (2)  (2)
    Viscosity-increasing property D D B B D B A
    (viscosity/mPa · s) × 103 (0.25) (0.35) (15) (25) (0.12) (15) (105)
    Sensation during use C D C C
    Long-term stability B B B B
  • [0078]
    As is apparent from the results shown in Tables 3 through 5, even when the present external composition containing the present microgel contains a large amount of a salt, the viscosity of the composition is not lowered. In addition, the present external composition exhibits excellent viscosity increasing property, provides good sensation during use; i.e., provides no sticky sensation during use, and exhibits excellent long-term stability.
  • Examples 25 and 26, Comparative Examples 12 and 13
  • [0079]
    Samples containing ingredients shown in the below-described Table 6 were prepared as follows.
  • [0080]
    Examples 25 and 26: Ingredients were mixed, heated to 90° C., dissolved, and then allowed to stand at room temperature, to thereby form a gel. The gel was pulverized with a homogenizer, to thereby yield a microgel (mean particle size: 100 μm).
  • [0081]
    Comparative Examples 12 and 13: Ingredients were mixed at 90° C., heating of the resultant mixture was stopped, and then the mixture was allowed to stand at room temperature.
  • [0082]
    Properties of the samples of Examples 25 and 26 and Comparative Examples 12 and 13 were evaluated. As shown in Table 6, the samples of Examples 25 and 26 exhibit consistency, and the samples of Comparative Examples 12 and 13 are gels (solid) having no consistency.
    TABLE 6
    Comp. Comp.
    Ex. 25 Ex. 26 Ex. 12 Ex. 13
    Carrageenan 1 2 1 2
    Glycerin 5 5 5 5
    Purified Balance Balance Balance Balance
    water
    Urea 5 5 5 5
    Preparation Pulverization Pulverization Mixing Mixing
    method after after under heat under heat
    gelation gelation
    Consistency Yes Yes No No
  • Example 27, Comparative Example 14 O/W Cream Viscosity Increasing Agent A
  • [0083]
    [0083]
    Ingredient Amount (mass %)
    (1) Agar 1.0
    (2) Keltrol 0.1
    (3) Purified water 98.9
  • [0084]
    <Preparation Method>
  • [0085]
    The above-listed ingredients (1) through (3) were mixed, dissolved at 90° C., and then cooled to form a gel. The gel was pulverized with a homogenizer, to thereby yield a microgel having a mean particle size of 100 μm (viscosity control agent A).
  • Emulsion Part A
  • [0086]
    [0086]
    Ingredient Amount (mass %)
    (1) Polyacrylic acid/polyalkylacrylate copolymer 0.1
    (2) Polydimethylsiloxane (6 mPa · s) 8.0
    (3) Potassium hydroxide 0.1
    (4) Purified water 91.8
  • [0087]
    <Preparation Method>
  • [0088]
    Ingredient (3) was added to ingredient (4), and to the resultant mixture were added ingredients (1) and (2), followed by mixing under stirring, to thereby yield emulsion part A.
  • [0089]
    Viscosity increasing agent A (50 mass %), ascorbic acid 2-glucoside (2 mass %), and emulsion part A (48 mass %) were mixed under stirring for emulsification, to thereby yield an O/W cream of Example 27.
  • [0090]
    Independently, ascorbic acid 2-glucoside (2 mass %) and emulsion part A (98 mass %) were mixed under stirring for emulsification, to thereby yield an O/W cream of Comparative Example 14.
  • [0091]
    The viscosity (25° C.) of each of the O/W creams prepared in Example 27 and Comparative Example 14 was measured by use of a B-type viscometer. The viscosity of the O/W cream of Example 27 and that of Comparative Example 14 were found to be 450,000 mPa·s and 20,000 mPa·s, respectively.
  • [0092]
    The results show that a compositional system which contains a pharmaceutical ingredient (whitening ingredient) and which fails to be thickened by a conventional viscosity control agent can be successfully thickened by the addition of the microgel of the present invention.
  • Example 28 Moisturizing Gel
  • [0093]
    [0093]
    Ingredient Amount (mass %)
     (1) Glycerin 7.0
     (2) Polyethylene glycol (PEG 1500) 8.0
     (3) Agar 2.0
     (4) Xanthan gum 0.2
     (5) Ascorbic acid 1.0
     (6) Tranexamic acid 0.5
     (7) Citric acid suitable amount
     (8) Sodium citrate suitable amount
     (9) Sodium hydroxide suitable amount
    (10) Purified water balance
    (11) Preservative suitable amount
    (12) Antioxidant suitable amount
    (13) Perfume suitable amount
  • [0094]
    <Preparation Method>
  • [0095]
    Ingredients (3) and (4) were added to ingredient (10), and the resultant mixture was dissolved at 90° C. The solution was cooled to 50° C., and the remaining ingredients; i.e., (1), (2), (5) through (9), and (11) through (13) were added thereto. The mixture was cooled to a temperature at 30° C. or lower to cause gelation. When the mixture became sufficiently solidified, the gel was pulverized with a high speed mixer (mean particle size: 50 μm), followed by deaeration, yielding a moisturizing gel. The amounts of ingredients (7) through (9) were appropriately controlled so that the pH was adjusted to 7.
  • [Example 29 Massage Cream (O/W)
  • [0096]
    [0096]
    Ingredient Amount (mass %)
     (1) Solid paraffin 5.0
     (2) Beeswax 10.0
     (3) Vaseline 15.0
     (4) Liquid paraffin 31.0
     (5) Glycerin 4.0
     (6) Glyceryl monostearate 2.0
     (7) POE(20) sorbitan monolaurate 2.0
     (8) Borax 1.0
     (9) Carrageenan 0.3
    (10) Succinoglycan 0.1
    (11) Purified water balance
    (12) Gultathione 0.1
    (13) Arbutin 3.0
    (14) Preservative suitable amount
    (15) Antioxidant suitable amount
    (16) Perfume suitable amount
  • [0097]
    <Preparation Method>
  • [0098]
    Ingredient (8) was added to a portion of ingredient (11), and the resultant mixture was heated to 70° C. (aqueous phase). Oily ingredients (1) to (6) were heated to melt, followed by addition of ingredient (7) thereto, and the resultant mixture was maintained at 70° C. The thus-obtained oily mixture was added gradually to the aqueous phase for preliminary emulsification, followed by treatment with a homogenizing mixer, to thereby yield emulsion particles of uniform size (emulsion part).
  • [0099]
    Independently, in the remaining portion of ingredient (11), ingredients (9), (10), and (12) through (16) were dissolved at 90° C., and subsequently, the resultant mixture was cooled to form a gel. The thus-obtained gel was thoroughly pulverized with a homogenizing mixer, to thereby yield a microgel (mean particle size: 70 μm) The microgel was added to the above-prepared emulsion part, and the resultant mixture was subjected to stirring, deaeration, filtration, and cooling, to thereby yield a massage cream (O/W).
  • Example 30 O/W Cream
  • [0100]
    [Emulsion Part B]
    Ingredient Amount (mass %)
    (1) Stearic acid 8.0
    (2) Stearyl alcohol 4.0
    (3) Butyl stearate 6.0
    (4) Propylene glycol 5.0
    (5) Glyceryl monostearate 2.0
    (6) Potassium hydroxide 0.4
    (7) Purified water balance
  • [0101]
    <Preparation Method>
  • [0102]
    To an aqueous phase (a mixture of ingredients (6) and (7)), ingredients (1) through (5) were added, followed by mixing under stirring, to thereby yield emulsion part B.
  • [0103]
    The thus-obtained emulsion part B (10 mass %), magnesium ascorbyl phosphate (3 mass %), and viscosity control agent A prepared in Example 27 (87 mass %) were mixed, to thereby yield an OW cream.
  • Example 31 O/W Cream Emulsion Part C
  • [0104]
    [0104]
    Ingredient Amount (mass %)
    (1) Solid paraffin 5.0
    (2) Beeswax 10.0
    (3) Vaseline 15.0
    (4) Liquid paraffin 41.0
    (5) 1,3-Butylene glycol 4.0
    (6) Glyceryl monostearate 2.0
    (7) POE(20) sorbitan monolaurate 2.0
    (8) Boric acid 0.2
    (9) Purified water balance
  • [0105]
    <Preparation Method>
  • [0106]
    To an aqueous phase (a mixture of ingredients (8) and (9)), ingredients (1) through (7) were added, followed by mixing under stirring, to thereby yield emulsion part C.
  • [0107]
    The thus-obtained emulsion part C (70 mass %), arbutin (2 mass %), and viscosity control agent A prepared in Example 27 (28 mass %) were mixed, to thereby yield an OW cream.
  • Example 32 Pack Emulsion Part D
  • [0108]
    [0108]
    Ingredient Amount (mass %)
     (1) Polyvinyl acetate emulsion 15.0
     (2) Polyvinyl alcohol 10.0
     (3) Sorbitol 5.0
     (4) Polyethylene glycol (PEG 400) 5.0
     (5) Jojoba oil 4.0
     (6) POE sorbitan monostearate 1.0
     (7) Titanium oxide 5.0
     (8) Talc 10.0
     (9) Ethanol 10.0
    (10) Purified water 37.0
  • [0109]
    <Preparation Method>
  • [0110]
    To an aqueous phase (a mixture of ingredients (9) and (10)), ingredients (1) through (8) were added, followed by mixing under stirring, to thereby yield emulsion part D.
  • [0111]
    The thus-obtained emulsion part D (80 mass %), ascorbic acid 2-glucoside (2 mass %), and viscosity control agent A prepared in Example 27 (18 mass %) were mixed, to thereby yield a pack.
  • [0112]
    The external compositions of the present invention prepared in Examples 27 through 32 were found to be endowed with excellent viscosity increasing property, and provided refreshing sensation during use with no sticky sensation. Moreover, the compositions were found to exhibit excellent whitening effect and long-term stability.
  • Example 33, Comparative Example 15 O/W Cream
  • [0113]
    Viscosity increasing agent A prepared in Example 27 (48 mass %), NaCl (2 mass %), and emulsion part A prepared in Example 27 (48 mass %) were mixed under stirring for emulsification, to thereby yield an O/W cream of Example 33.
  • [0114]
    Independently, NaCl (2 mass %) and emulsion part A prepared in Example 27 (98 mass %) were mixed under stirring for emulsification, to thereby yield an OW cream of Comparative Example 15.
  • [0115]
    The viscosity (25° C.) of each of the O/W creams prepared in Example 33 and Comparative Example 15 was measured by use of a B-type viscometer. The viscosity of the O/W cream of Example 33 and that of Comparative Example 15 were found to be 400,000 mPa·s and 18,000 mPa·s, respectively.
  • [0116]
    The results show that a salt-containing compositional system which fails to be thickened by a conventional viscosity control agent can be successfully thickened by the addition of the microgel of the present invention.
  • Example 34 Massage Cream (O/W)
  • [0117]
    [0117]
    Ingredient Amount (mass %)
     (1) Solid paraffin 5.0
     (2) Beeswax 10.0
     (3) Vaseline 15.0
     (4) Liquid paraffin 31.0
     (5) Glycerin 4.0
     (6) Glyceryl monostearate 2.0
     (7) POE(20) sorbitan monolaurate 2.0
     (8) Borax 1.0
     (9) Carrageenan 0.3
    (10) Succinoglycan 0.1
    (11) Purified water balance
    (12) Preservative suitable amount
    (13) Antioxidant suitable amount
    (14) Perfume suitable amount
  • [0118]
    <Preparation Method>
  • [0119]
    Ingredient (8) was added to a portion of ingredient (11), and the resultant mixture was heated to 70° C. (aqueous phase). Oily ingredients (1) through (6) were heated to melt, followed by addition of ingredient (7) thereto, and the resultant mixture was maintained at 70° C. The thus-prepared oily mixture was gradually added to the aqueous phase for preliminary emulsification, followed by treatment with a homogenizing mixer, to thereby yield emulsion particles of uniform size (emulsion part).
  • [0120]
    In the remaining portion of ingredient (11), ingredients (9), (10), and (12) through (14) were dissolved at 90° C., and subsequently, the resultant mixture was cooled to form a gel. The thus-obtained gel was thoroughly pulverized with a homogenizing mixer, to thereby yield a microgel (mean particle size: 80 μm). The microgel was added to the above-prepared emulsion part, and the resultant mixture was subjected to mixing under stirring, deaeration, filtration, and cooling, to thereby yield a massage cream (O/W).
  • Example 35 Hair-Setting Gel
  • [0121]
    [0121]
    Ingredient Amount (mass %)
     (1) Carboxyvinyl polymer 0.7
     (2) Polyvinyl pyrrolidone 2.0
     (3) Glycerin 3.0
     (4) Sodium hydroxide suitable amount
     (5) Hydrochloric acid suitable amount
     (6) Ethanol 5.0
     (7) Curdlan 1.0
     (8) Xanthan gum 0.2
     (9) Polyoxyethylene octyldodecyl ether suitable amount
    (10) Perfume suitable amount
    (11) Chelating agent suitable amount
    (12) Purified water balance
  • [0122]
    <Preparation Method>
  • [0123]
    Ingredient (1) was dispersed in a mixture consisting of ingredient (3) and a portion of ingredient (12) so as to form a dispersion. Ingredient (2), a portion of ingredient (4), ingredient (6), and ingredients (9) through (11) were dissolved in the remaining portion of ingredient (12), and the resultant mixture was added to the above-prepared dispersion, yielding a mixed solution. Ingredient (7) was dissolved in the remaining portion of (4), ingredient (8) was added thereto and dissolved therein, and the mixture was neutralized with ingredient (5). The resultant neutral solution was added to the aforementioned mixed solution, and heated at 80° C. for 10 minutes. Subsequently, the formed gel was subjected to pulverizing with a homogenizer (mean particle size: 80 μm), filtration, deaeration, and cooling, to thereby yield a hair-setting gel.
  • Example 36 O/W Cream
  • [0124]
    [Emulsion Part E]
    Ingredient Amount (mass %)
    (1) Stearic acid 8.0
    (2) Stearyl alcohol 4.0
    (3) Butyl stearate 6.0
    (4) Propylene glycol 5.0
    (5) Glyceryl monostearate 2.0
    (6) Potassium hydroxide 0.4
    (7) Purified water balance
  • [0125]
    <Preparation Method>
  • [0126]
    To an aqueous phase (a mixture of ingredients (6) and (7)), the remaining ingredients were added, followed by mixing under stirring, to thereby yield emulsion part E.
  • [0127]
    The thus-prepared emulsion part E (30 mass %), caffeine (1 mass %), and viscosity control agent A prepared in Example 27 (69 mass %) were mixed, to thereby yield an O/W cream.
  • Example 37 O/W Cream Emulsion Part F
  • [0128]
    [0128]
    Ingredient Amount (mass %)
    (1) Solid paraffin 5.0
    (2) Beeswax 10.0
    (3) Vaseline 15.0
    (4) Liquid paraffin 41.0
    (5) 1,3-Butylene glycol 4.0
    (6) Glyceryl monostearate 2.0
    (7) POE(20) sorbitan monolaurate 2.0
    (8) Boric acid 0.2
    (9) Purified water balance
  • [0129]
    <Preparation Method>
  • [0130]
    To an aqueous phase (a mixture of ingredients (8) and (9)), the remaining ingredients were added, followed by mixing under stirring, to thereby yield emulsion part F.
  • [0131]
    The thus-prepared emulsion part F (70 mass %), aspartic acid (1 mass %), and viscosity control agent A prepared in Example 27 (29 mass %) were mixed, to thereby yield an O/W cream.
  • Example 38 Pack
  • [0132]
    [Emulsion Part G]
    Ingredient Amount (mass %)
     (1) Polyvinyl acetate emulsion 15.0
     (2) Polyvinyl alcohol 10.0
     (3) Sorbitol 5.0
     (4) Polyethylene glycol (PEG 400) 5.0
     (5) Jojoba oil 4.0
     (6) POE sorbitan monostearate 1.0
     (7) Titanium oxide 5.0
     (8) Talc 10.0
     (9) Ethanol 10.0
    (10) Purified water 37.0
  • [0133]
    <Preparation Method>
  • [0134]
    To an aqueous phase (a mixture of ingredients (9) and (10)), the remaining ingredients were added, followed by mixing under stirring, to thereby yield emulsion part G.
  • [0135]
    The thus-obtained emulsion part G (80 mass %), dipotassium glycyrrihizinate (0.5 mass %), and viscosity control agent A prepared in Example 27 (19.5 mass %) were mixed, to thereby yield a pack.
  • [0136]
    The external compositions of the present invention prepared in Examples 33 through 38 were found to be endowed with excellent viscosity increasing property, and provided refreshing sensation during use with no sticky sensation. Moreover, the compositions were found to exhibit excellent long-term stability.
  • Example 39, Comparative Example 16 OW Cream
  • [0137]
    [0137]
    Ingredient Amount (mass %)
    (1) Squalane 10.0 
    (2) Vaseline 5.0
    (3) 1,3-Butylene glycol 4.0
    (4) Glyceryl monostearate 2.0
    (5) POE(20) sorbitan monolaurate 2.0
    (6) Agar 1.5
    (7) Keltrol 0.2
    (8) Purified water balance
  • [0138]
    <Preparation Method 1>
  • [0139]
    Ingredients (3) through (7) were added to ingredient (8), and the resultant mixture was heated to 90° C. to dissolve. The solution was continuously stirred, and ingredients (1) and (2) were added thereto at 70° C. The thus-obtained mixture was cooled under stirring to room temperature, to thereby yield an O/W cream.
  • [0140]
    <Preparation Method 2>
  • [0141]
    Ingredients (3), (6), and (7) were added to ingredient (8) (50 mass %), and the mixture was heated to dissolve, then cooled for gelation. The resultant gel was pulverized, to thereby yield a paste-like aqueous gel (mean particle size: 80 μm). The thus-prepared paste-like aqueous gel was mixed thoroughly with an O/W cream; which had been prepared by addition of ingredients (4) and (5) to the remaining portion of ingredient (8) followed by further addition of ingredients (1) and (2) thereto at 70° C., to thereby yield an emulsified product (O/W cream).
  • [0142]
    The viscosity (25° C.) of each of the O/W creams prepared through preparation method 1 or 2 was measured by use of a B-type viscometer. The viscosity of the O/W cream prepared through preparation method 1 and that through preparation method 2 were found to be 140,000 mPa·s and 300,000 mPa·s, respectively. Thus, it has been confirmed that even though the composition per se is identical, a compositional system including microgel obtained through pulverization of a gel exhibits excellent viscosity increasing property as compared with a compositional system including no such microgel.
  • Example 40 Moisturizing Gel
  • [0143]
    [0143]
    Ingredient Amount (mass %)
     (1) Purified water balance
     (2) Agar 2.0
     (3) Dipropylene glycol 10.0 
     (4) Trimethylglycine 5.0
     (5) Hyaluronic acid 0.1
     (6) Sodium polyacrylate 0.2
     (7) Polyacrylamide 0.5
     (8) Silica powder 1.0
     (9) EDTA suitable amount
    (10) Citric acid suitable amount
    (11) Perfume suitable amount
    (12) Preservative suitable amount
  • [0144]
    <Preparation Method>
  • [0145]
    Ingredients (2) through (7) and (9) through (12) were added to ingredient (1), and the resultant mixture was caused to dissolve at a temperature of not lower than 85° C. Subsequently, the solution was allowed to cool to a temperature equal to or below 30° C. for solidification. Ingredient (8) was added thereto, followed by pulverization with a homogenizer to thereby yield a microgel (mean particle size: 40 μm) . The thus-prepared microgel was homogeneously dispersed, to thereby yield a moisturizing gel.
  • Example 41 Moisturizing Cream
  • [0146]
    [0146]
    Ingredient Amount (mass %)
     (1) Purified water balance
     (2) Agar 1.5
     (3) Dipropylene glycol 10.0 
     (4) Xylitol 5.0
     (5) Hyaluronic acid 0.1
     (6) Polyacrylamide 0.5
     (7) Cyclic silicone 5.0
     (8) Squalane 5.0
     (9) Acrylic acid/Alkyl acrylate copolymer 0.2
    (10) EDTA suitable amount
    (11) Triethanolamine suitable amount
    (12) Citric acid suitable amount
    (13) Perfume suitable amount
    (14) Preservative suitable amount
  • [0147]
    <Preparation Method>
  • [0148]
    Ingredients (2) through (6), (10), (12), and (14) were added to a portion of ingredient (1), and the resultant mixture was caused to dissolve at a temperature of not lower than 85° C. The solution was allowed to cool to a temperature equal to or below 30° C. for solidification. The solid was thoroughly pulverized with a homogenizer, to thereby yield a microgel (mean particle size: 70 μm). To the resultant microgel, an emulsified product which had been prepared through addition of ingredient (11) to a homogeneously dispersed mixture of ingredients (7) through (9), and (13) in the remaining portion of ingredient (1) followed by a treatment with a homogenizing mixer to obtain a homogeous emulsion was added, and subsequently, the thus-obtained mixture was subjected to homogeneous dispersion, to thereby yield a moisturizing cream.
  • Example 42 Pack
  • [0149]
    [0149]
    Ingredient Amount (mass %)
     (1) Purified water balance
     (2) Agar 1.5
     (3) Glycerin 15.0 
     (4) Polyethylene glycol (PEG 300) 5.0
     (5) Montmorillonite 3.0
     (6) Spherical resin powder (Poly(alkyl acrylate)) 3.0
     (7) Zinc white 1.0
     (8) Glycyrrhizic acid salt suitable amount
     (9) Xanthan gum 0.2
    (10) EDTA suitable amount
    (11) Lactic acid suitable amount
    (12) Perfume suitable amount
    (13) Preservative suitable amount
  • [0150]
    <Preparation Method>
  • [0151]
    Ingredients (2) through (4) and (8) through (13) were added to ingredient (1), and the resultant mixture was caused to dissolve at a temperature of not lower than 85° C. The solution was allowed to cool to a temperature equal to or below 30° C. for solidification. The solid was thoroughly pulverized with a homogenizer to thereby form a microgel (mean particle size: 60 μm) . To the resultant microgel, ingredients (5) through (7) were added and the resultant mixture was dispersed homogeneously, to thereby yield a pack.
  • Example 43 Eye Gel
  • [0152]
    [0152]
    Ingredient Amount (mass %)
     (1) Purified water balance
     (2) Agar 2.0
     (3) Glycerin 10.0 
     (4) Polyvinyl alcohol 1.0
     (5) Polyacrylamide 0.2
     (6) Trimethylsiloxysilicate 1.0
     (7) Dimethylpolysiloxane 5.0
     (8) Sodium chloride 0.5
     (9) Acrylic acid/Alkyl acrylate copolymer 0.1
    (10) EDTA suitable amount
    (11) Citric acid suitable amount
    (12) Perfume suitable amount
    (13) Preservative suitable amount
  • [0153]
    <Preparation Method>
  • [0154]
    Ingredients (2) through (5), (8), (10), (11), and (13) were added to a portion of ingredient (1), and the resultant mixture was caused to dissolve at a temperature of not lower than 85° C. The solution was allowed to cool to a temperature equal to or below 30° C. for solidification. The solid was thoroughly pulverized with a homogenizer, to thereby form a microgel (mean particle size: 70 μm) . To the resultant microgel, a homogeneously dispersed mixture which had been prepared through addition of ingredients (6), (7), (9), and (12) to the remaining portion of ingredient (1) followed by dispersion with a homogenizing mixer was added, and subsequently, the thus-obtained mixture was subjected to further dispersion, to thereby yield an eye gel.
  • Example 44 Jelly Pack
  • [0155]
    [0155]
    Ingredient Amount (mass %)
     (1) Purified water balance
     (2) Agar 1.5
     (3) Butylene glycol 10.0 
     (4) Ethanol 12.0 
     (5) Polyacrylamide 0.2
     (6) Carboxyvinyl polymer 0.5
     (7) Sodium chloride 0.5
     (8) Potassium hydroxide suitable amount
     (9) EDTA suitable amount
    (10) Citric acid suitable amount
    (11) Perfume suitable amount
    (12) Preservative suitable amount
  • [0156]
    <Preparation Method>
  • [0157]
    Ingredients (2) through (12) were added to ingredient (1), and the resultant mixture was caused to dissolve at a temperature of not lower than 85° C. The solution was allowed to cool to a temperature equal to or below 30° C. for solidification. The solid was thoroughly pulverized with a homogenizer for formation of microgel (mean particle size: 80 μm), to thereby yield a jelly pack.
  • [0158]
    The external compositions of the present invention prepared in Examples 40 through 44 were found to be endowed with excellent viscosity increasing property, and provided refreshing sensation during use with no sticky sensation. Moreover, the compositions were found to exhibit excellent long-term stability.
  • Example 45 Two-Agent Type Hair Manicure (Acid Hair Dye)
  • [0159]
    [0159]
    Ingredient Amount (mass %)
    [Agent 1]
    Ethanol 16.0
    Purified water to 40.0
    Benzyl alcohol 8.0
    Glycolic acid 1.6
    Sodium lactate (50%) 0.6
    Colorant 0.06
    [Agent 2]
    Ethanol 4.0
    Purified water to 60.0
    Agar (Ina Agar AX100) 2.0
    Methylparaben suitable amount
  • [0160]
    <Preparation Method>
  • [0161]
    Agent 1: Ethanol and benzyl alcohol were mixed with purified water. To the resultant mixture, glycolic acid and sodium lactate were dissolved, and the colorant was added thereto and caused to dissolve, to thereby yield an agent 1.
  • [0162]
    Agent 2: Agar was dissolved in purified water (75° C.). Methylparaben and ethanol were added to the resultant solution, and the mixture was allowed to stand for 12 hours at room temperature. The thus-solidified agar gel was pulverized with a high speed mixer (mean particle size: 70 μm, to thereby yield an agent 2 (an agar microgel).
  • [0163]
    The acid hair dye prepared from mixing the agents 1 and 2 was found to exhibit satisfactory viscosity stability and adhesion, and was also found to have excellent sensation during use.
  • Example 46 One-Agent Type Hair Manicure (Acid Hair Dye)
  • [0164]
    [0164]
    Ingredient Amount mass %
    Purified water to 100.0
    1,3-Butylene glycol 20.0
    Benzyl alcohol 8.0
    Glycolic acid 0.2
    Colorant suitable amount
    Hydroxyethylcellulose 0.5
    Agar (Ina Agar AX100) 2.0
    Amino-denatured silicone 0.5
    Methylpolysiloxane (20 cs) 0.1
    Stearyl trimethyl ammonium chloride 0.1
  • [0165]
    <Preparation Method>
  • [0166]
    Agar was dissolved in a portion of purified water (75° C.). The solution was allowed to cool to 60° C., followed by addition of 1,3-butylene glycol, benzyl alcohol, glycolic acid, and hydroxyethylcellulose thereto. The mixture was caused to dissolve, and subsequently the resultant solution was allowed to stand for 12 hours at room temperature. The solidified agar gel was pulverized with a high speed mixer until a microgel having a mean particle size of 50 μm was yielded. The colorant dissolved in another portion of purified water was added to the thus-obtained microgel, and finally, amino-denatured silicone, methylpolysiloxane (20 cs), and the remaining portion of purified water in which stearyl trimethyl ammonium chloride had been dissolved were added thereto, to thereby yield an acid hair dye.
  • [0167]
    The acid hair dye prepared in Example 46 was found to exhibit high viscosity stability and adhesion, and was found to be endowed with excellent sensation during use.
  • INDUSTRIAL APPLICABILITY
  • [0168]
    The microgel of the present invention does not exhibit even slightest spinnability, which is unique to polymer solutions conventionally used as viscosity control agents, and an external composition containing the microgel provides a very refreshing sensation during use. Although polymer solutions may in some cases be affected by a pharmaceutical ingredient or salt incorporated therein, to thereby cause a reduced viscosity and limitation in terms of pharmaceutical ingredients or salts which can be incorporated, the microgel of the present invention does not involve such problems, and a broad range of external compositions, including cosmetic compositions, can be prepared by use of the microgel.

Claims (14)

  1. 1. A microgel having a mean particle size of 0.1-1,000 μm, the microgel being produced from a gel which is formed by use of a hydrophilic compound capable of forming a gel.
  2. 2. A microgel having a mean particle size of 0.1-1,000 μm, the microgel being produced from a gel which is formed by use of a hydrophilic compound capable of forming a gel and a viscosity increasing compound incapable of forming a gel.
  3. 3. A microgel as described in claim 2, wherein the viscosity increasing compound incapable of forming a gel is one or more viscosity increasing compounds selected from the group consisting of xanthan gum, succinoglycan, polyacrylic acid, polyethylene glycol, polyacrylamide, and a polyalkylacrylamide/polyacrylamide copolymer.
  4. 4. A microgel as described in any one of claims 1 through 3, wherein the hydrophilic compound capable of forming a gel is one or more hydrophilic compounds selected from the group consisting of agar, carrageenan, curdlan, gelatin, gellan gum, and alginic acid.
  5. 5. A microgel as described in any one of claims 1 through 4, which has a viscosity of 2,000-1,000,000 mPa·s (B-type viscometer, 25° C.)
  6. 6. A process for producing a microgel of claim 1, which process comprises dissolving in an aqueous solvent a hydrophilic compound capable of forming a gel; causing the resultant mixture to form a gel; and pulverizing the gel into a microgel having a mean particle size of 0.1-1,000 μm.
  7. 7. A process for producing a microgel of claim 2, which process comprising dissolving in an aqueous solvent a hydrophilic compound capable of forming a gel and a viscosity increasing compound incapable of forming a gel; causing the resultant mixture to form a gel; and pulverizing the gel into a microgel having a mean particle size of 0.1-1,000 μm.
  8. 8. An external composition comprising a microgel of any one of claims 1 through 5.
  9. 9. An external composition as described in claim 8, further comprising a pharmaceutical ingredient and/or a salt.
  10. 10. An external composition as described in claim 9, wherein the pharmaceutical ingredient is a whitening ingredient.
  11. 11. An external composition as described in claim 10, wherein the whitening ingredient is one or more whitening ingredients selected from the group consisting of L-ascorbic acid, an L-ascorbic acid derivative, arbutin, glutathione, tranexamic acid, a tranexamic acid derivative, a placenta extract, and a vegetable extract exhibiting whitening effect.
  12. 12. An external composition as described in any one of claims 9 through 11, wherein the amount of the pharmaceutical ingredient and/or the salt is 0.01-20 mass % of the total of the composition.
  13. 13. An external composition as described in any one of claims 8 through 12, which is a cosmetic composition.
  14. 14. An external composition as described in any one of claims 8 through 12, which is a hair dye.
US09936317 2000-01-11 2001-01-11 Microgel and external compositions containing the same Abandoned US20030072805A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP2000002610 2000-01-11
JP2000002611 2000-01-11
JP2000094308 2000-03-30
JP2000-2610 2000-03-30
JP2000094307 2000-03-30
JP2000-94308 2000-03-30
JP2000-94307 2000-03-30
JP2000-2611 2000-03-30

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12082130 US8367082B2 (en) 2000-01-11 2008-04-09 Microgel and external compositions containing the same

Publications (1)

Publication Number Publication Date
US20030072805A1 true true US20030072805A1 (en) 2003-04-17

Family

ID=27480912

Family Applications (2)

Application Number Title Priority Date Filing Date
US09936317 Abandoned US20030072805A1 (en) 2000-01-11 2001-01-11 Microgel and external compositions containing the same
US12082130 Active 2024-02-20 US8367082B2 (en) 2000-01-11 2008-04-09 Microgel and external compositions containing the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12082130 Active 2024-02-20 US8367082B2 (en) 2000-01-11 2008-04-09 Microgel and external compositions containing the same

Country Status (3)

Country Link
US (2) US20030072805A1 (en)
EP (1) EP1158021B1 (en)
WO (1) WO2001051558A1 (en)

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050048128A1 (en) * 2001-09-27 2005-03-03 Satomi Miyata Process for producing collagen production enhancers and use thereof
US20050169869A1 (en) * 2003-11-18 2005-08-04 L'oreal Cosmetic composition comprising at least one gellan gum or derivative thereof, at least one monovalent salt, and at least one suspension compound, processes using this composition, and uses thereof
US20050281881A1 (en) * 2002-12-23 2005-12-22 Beiersdorf Ag Self-adhesive polymer matrix containing sea algae extract and glycerin
US20060094635A1 (en) * 2004-11-01 2006-05-04 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Aqueous cleansing composition with gel flakes
WO2009131323A2 (en) * 2008-04-25 2009-10-29 주식회사 메가젠임플란트 Hyaluronic acid bone-filling complex and fabrication method thereof
US20100112076A1 (en) * 2008-03-07 2010-05-06 Ravi Palaniappan Gellan-Gum Nanoparticles and Methods of Making and Using the Same
US8388541B2 (en) 2007-11-26 2013-03-05 C. R. Bard, Inc. Integrated system for intravascular placement of a catheter
US8388546B2 (en) 2006-10-23 2013-03-05 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US8437833B2 (en) 2008-10-07 2013-05-07 Bard Access Systems, Inc. Percutaneous magnetic gastrostomy
WO2013076212A2 (en) 2011-11-25 2013-05-30 L'oreal Cosmetic composition including a combination of a gelifiable water-soluble polysaccharide, starch and fillers
US8478382B2 (en) 2008-02-11 2013-07-02 C. R. Bard, Inc. Systems and methods for positioning a catheter
US8512256B2 (en) 2006-10-23 2013-08-20 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
USD699359S1 (en) 2011-08-09 2014-02-11 C. R. Bard, Inc. Ultrasound probe head
US8781555B2 (en) 2007-11-26 2014-07-15 C. R. Bard, Inc. System for placement of a catheter including a signal-generating stylet
US8784336B2 (en) 2005-08-24 2014-07-22 C. R. Bard, Inc. Stylet apparatuses and methods of manufacture
US8801693B2 (en) 2010-10-29 2014-08-12 C. R. Bard, Inc. Bioimpedance-assisted placement of a medical device
US8849382B2 (en) 2007-11-26 2014-09-30 C. R. Bard, Inc. Apparatus and display methods relating to intravascular placement of a catheter
USD724745S1 (en) 2011-08-09 2015-03-17 C. R. Bard, Inc. Cap for an ultrasound probe
CN104755072A (en) * 2012-11-13 2015-07-01 詹尼克公司 Sticky hydrogel cosmetic composition
US9125578B2 (en) 2009-06-12 2015-09-08 Bard Access Systems, Inc. Apparatus and method for catheter navigation and tip location
US9211107B2 (en) 2011-11-07 2015-12-15 C. R. Bard, Inc. Ruggedized ultrasound hydrogel insert
US9339206B2 (en) 2009-06-12 2016-05-17 Bard Access Systems, Inc. Adaptor for endovascular electrocardiography
US9445734B2 (en) 2009-06-12 2016-09-20 Bard Access Systems, Inc. Devices and methods for endovascular electrography
US9456766B2 (en) 2007-11-26 2016-10-04 C. R. Bard, Inc. Apparatus for use with needle insertion guidance system
US9492097B2 (en) 2007-11-26 2016-11-15 C. R. Bard, Inc. Needle length determination and calibration for insertion guidance system
US9521961B2 (en) 2007-11-26 2016-12-20 C. R. Bard, Inc. Systems and methods for guiding a medical instrument
US9532724B2 (en) 2009-06-12 2017-01-03 Bard Access Systems, Inc. Apparatus and method for catheter navigation using endovascular energy mapping
US9554716B2 (en) 2007-11-26 2017-01-31 C. R. Bard, Inc. Insertion guidance system for needles and medical components
US9636031B2 (en) 2007-11-26 2017-05-02 C.R. Bard, Inc. Stylets for use with apparatus for intravascular placement of a catheter
US9649048B2 (en) 2007-11-26 2017-05-16 C. R. Bard, Inc. Systems and methods for breaching a sterile field for intravascular placement of a catheter
US9839372B2 (en) 2014-02-06 2017-12-12 C. R. Bard, Inc. Systems and methods for guidance and placement of an intravascular device
US9901714B2 (en) 2008-08-22 2018-02-27 C. R. Bard, Inc. Catheter assembly including ECG sensor and magnetic assemblies
US9999371B2 (en) 2012-10-31 2018-06-19 C. R. Bard, Inc. Integrated system for intravascular placement of a catheter

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4046313B2 (en) * 2001-01-12 2008-02-13 株式会社資生堂 Water-in-oil emulsion composition and emulsified cosmetic using the same
KR100820625B1 (en) * 2002-01-18 2008-04-10 가부시키가이샤 시세이도 Water-in-oil emulsion composition and emulsion cosmetic comprising the same
US20040097385A1 (en) * 2002-11-18 2004-05-20 Unilever Home & Personal Products Usa, Division Of Conopco, Inc. Viscoelastic cleansing gel with surfactant solutions containing polysaccharides and their derivatives polysaccharide hydrocolloids
US7993654B2 (en) 2002-12-23 2011-08-09 Beiersdorf Ag Self-adhesive polymer matrix containing sea algae extract
DE10260872B4 (en) * 2002-12-23 2013-09-26 Beiersdorf Ag Use of the gel-forming polymer, water, alcohol and seaweed extract for adjusting elasticity and adhesion self-adhesive cosmetic polymer matrices
EP2234594A4 (en) 2007-12-19 2013-01-16 Elc Man Llc Compositions and methods for treating skin with extract from trametes
JP4840829B2 (en) * 2009-09-01 2011-12-21 株式会社 資生堂 Sunscreen cosmetics
JP5030243B2 (en) * 2010-01-21 2012-09-19 株式会社 資生堂 External composition
JP4979095B2 (en) * 2010-04-28 2012-07-18 株式会社 資生堂 Thickening compositions and cosmetics containing the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360624A (en) * 1991-06-24 1994-11-01 Takeda Chemical Industries, Ltd. Emulsion-type food
US5976500A (en) * 1990-04-10 1999-11-02 Imarx Pharmaceutical Corp. Gel particle contrast media for magnetic resonance imaging
US20020006414A1 (en) * 1997-05-30 2002-01-17 Katsumi Murata External composition for skin comprising sphingoglycolipid
US6391288B1 (en) * 1999-07-27 2002-05-21 Shiseido Co., Ltd. Microcapsule and method of making the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2607263B2 (en) * 1988-04-18 1997-05-07 三栄源エフ・エフ・アイ株式会社 Thickening, gelling method
JP2731397B2 (en) * 1988-07-05 1998-03-25 三栄源エフ・エフ・アイ株式会社 Method of manufacturing the instant thickening gel product
EP0355908B1 (en) 1988-08-17 1996-12-18 Unilever N.V. Liquid based composition comprising gelling polysaccharide capable of forming a reversible gel and a method for preparing such composition
JPH0611793B2 (en) * 1989-08-17 1994-02-16 旭化成工業株式会社 Suspension and a method of manufacturing fine cellulosic material
GB8928370D0 (en) * 1989-12-15 1990-02-21 Unilever Plc Fluid composition
JPH05255538A (en) * 1991-08-01 1993-10-05 Asahi Chem Ind Co Ltd Composition of pulverized cellulose suspension
DE69304952T2 (en) * 1992-02-26 1997-02-20 Unilever Nv Emulsions, water continuous based on polysaccharides
JPH10279693A (en) * 1997-04-03 1998-10-20 Fuji Xerox Co Ltd Production of water-absorbing gel particle
EP0911017A3 (en) * 1997-10-28 2001-10-31 Kao Corporation External skin-care composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976500A (en) * 1990-04-10 1999-11-02 Imarx Pharmaceutical Corp. Gel particle contrast media for magnetic resonance imaging
US5360624A (en) * 1991-06-24 1994-11-01 Takeda Chemical Industries, Ltd. Emulsion-type food
US20020006414A1 (en) * 1997-05-30 2002-01-17 Katsumi Murata External composition for skin comprising sphingoglycolipid
US6391288B1 (en) * 1999-07-27 2002-05-21 Shiseido Co., Ltd. Microcapsule and method of making the same

Cited By (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050048128A1 (en) * 2001-09-27 2005-03-03 Satomi Miyata Process for producing collagen production enhancers and use thereof
US20050281881A1 (en) * 2002-12-23 2005-12-22 Beiersdorf Ag Self-adhesive polymer matrix containing sea algae extract and glycerin
US7829099B2 (en) 2002-12-23 2010-11-09 Beiersdorf Ag Self-adhesive polymer matrix containing sea algae extract and glycerin
US20050169869A1 (en) * 2003-11-18 2005-08-04 L'oreal Cosmetic composition comprising at least one gellan gum or derivative thereof, at least one monovalent salt, and at least one suspension compound, processes using this composition, and uses thereof
US8399001B2 (en) 2003-11-18 2013-03-19 L'oreal Cosmetic composition comprising at least one gellan gum or derivative thereof, at least one monovalent salt, and at least one suspension compound, processes using this composition, and uses thereof
US20060094635A1 (en) * 2004-11-01 2006-05-04 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Aqueous cleansing composition with gel flakes
US8784336B2 (en) 2005-08-24 2014-07-22 C. R. Bard, Inc. Stylet apparatuses and methods of manufacture
US9345422B2 (en) 2006-10-23 2016-05-24 Bard Acess Systems, Inc. Method of locating the tip of a central venous catheter
US8858455B2 (en) 2006-10-23 2014-10-14 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US8774907B2 (en) 2006-10-23 2014-07-08 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US8388546B2 (en) 2006-10-23 2013-03-05 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US9833169B2 (en) 2006-10-23 2017-12-05 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US8512256B2 (en) 2006-10-23 2013-08-20 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US9265443B2 (en) 2006-10-23 2016-02-23 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US9636031B2 (en) 2007-11-26 2017-05-02 C.R. Bard, Inc. Stylets for use with apparatus for intravascular placement of a catheter
US9649048B2 (en) 2007-11-26 2017-05-16 C. R. Bard, Inc. Systems and methods for breaching a sterile field for intravascular placement of a catheter
US9554716B2 (en) 2007-11-26 2017-01-31 C. R. Bard, Inc. Insertion guidance system for needles and medical components
US8388541B2 (en) 2007-11-26 2013-03-05 C. R. Bard, Inc. Integrated system for intravascular placement of a catheter
US8781555B2 (en) 2007-11-26 2014-07-15 C. R. Bard, Inc. System for placement of a catheter including a signal-generating stylet
US9456766B2 (en) 2007-11-26 2016-10-04 C. R. Bard, Inc. Apparatus for use with needle insertion guidance system
US9549685B2 (en) 2007-11-26 2017-01-24 C. R. Bard, Inc. Apparatus and display methods relating to intravascular placement of a catheter
US8849382B2 (en) 2007-11-26 2014-09-30 C. R. Bard, Inc. Apparatus and display methods relating to intravascular placement of a catheter
US9681823B2 (en) 2007-11-26 2017-06-20 C. R. Bard, Inc. Integrated system for intravascular placement of a catheter
US9492097B2 (en) 2007-11-26 2016-11-15 C. R. Bard, Inc. Needle length determination and calibration for insertion guidance system
US9521961B2 (en) 2007-11-26 2016-12-20 C. R. Bard, Inc. Systems and methods for guiding a medical instrument
US9526440B2 (en) 2007-11-26 2016-12-27 C.R. Bard, Inc. System for placement of a catheter including a signal-generating stylet
US8971994B2 (en) 2008-02-11 2015-03-03 C. R. Bard, Inc. Systems and methods for positioning a catheter
US8478382B2 (en) 2008-02-11 2013-07-02 C. R. Bard, Inc. Systems and methods for positioning a catheter
US8389012B2 (en) * 2008-03-07 2013-03-05 The Corporation Of Mercer University Gellan-gum nanoparticles and methods of making and using the same
US20100112076A1 (en) * 2008-03-07 2010-05-06 Ravi Palaniappan Gellan-Gum Nanoparticles and Methods of Making and Using the Same
WO2009131323A2 (en) * 2008-04-25 2009-10-29 주식회사 메가젠임플란트 Hyaluronic acid bone-filling complex and fabrication method thereof
WO2009131323A3 (en) * 2008-04-25 2009-12-23 주식회사 메가젠임플란트 Hyaluronic acid bone-filling complex and fabrication method thereof
US9901714B2 (en) 2008-08-22 2018-02-27 C. R. Bard, Inc. Catheter assembly including ECG sensor and magnetic assemblies
US8437833B2 (en) 2008-10-07 2013-05-07 Bard Access Systems, Inc. Percutaneous magnetic gastrostomy
US9907513B2 (en) 2008-10-07 2018-03-06 Bard Access Systems, Inc. Percutaneous magnetic gastrostomy
US9532724B2 (en) 2009-06-12 2017-01-03 Bard Access Systems, Inc. Apparatus and method for catheter navigation using endovascular energy mapping
US9445734B2 (en) 2009-06-12 2016-09-20 Bard Access Systems, Inc. Devices and methods for endovascular electrography
US9125578B2 (en) 2009-06-12 2015-09-08 Bard Access Systems, Inc. Apparatus and method for catheter navigation and tip location
US9339206B2 (en) 2009-06-12 2016-05-17 Bard Access Systems, Inc. Adaptor for endovascular electrocardiography
US9415188B2 (en) 2010-10-29 2016-08-16 C. R. Bard, Inc. Bioimpedance-assisted placement of a medical device
US8801693B2 (en) 2010-10-29 2014-08-12 C. R. Bard, Inc. Bioimpedance-assisted placement of a medical device
USD754357S1 (en) 2011-08-09 2016-04-19 C. R. Bard, Inc. Ultrasound probe head
USD699359S1 (en) 2011-08-09 2014-02-11 C. R. Bard, Inc. Ultrasound probe head
USD724745S1 (en) 2011-08-09 2015-03-17 C. R. Bard, Inc. Cap for an ultrasound probe
US9211107B2 (en) 2011-11-07 2015-12-15 C. R. Bard, Inc. Ruggedized ultrasound hydrogel insert
WO2013076212A2 (en) 2011-11-25 2013-05-30 L'oreal Cosmetic composition including a combination of a gelifiable water-soluble polysaccharide, starch and fillers
US9999371B2 (en) 2012-10-31 2018-06-19 C. R. Bard, Inc. Integrated system for intravascular placement of a catheter
CN104755072A (en) * 2012-11-13 2015-07-01 詹尼克公司 Sticky hydrogel cosmetic composition
US9839372B2 (en) 2014-02-06 2017-12-12 C. R. Bard, Inc. Systems and methods for guidance and placement of an intravascular device

Also Published As

Publication number Publication date Type
US8367082B2 (en) 2013-02-05 grant
EP1158021B1 (en) 2011-10-05 grant
US20090047312A1 (en) 2009-02-19 application
WO2001051558A1 (en) 2001-07-19 application
EP1158021A1 (en) 2001-11-28 application
EP1158021A4 (en) 2006-04-12 application

Similar Documents

Publication Publication Date Title
US6391288B1 (en) Microcapsule and method of making the same
US5891452A (en) Cosmetic or dermatological composition containing at least one active principle precursor and a crosslinked poly(2-acrylamido-2-methylpropanesulphonic acid) polymer neutralized to at least 90%
EP0331833A1 (en) Water-in-oil emulsion type cosmetics
US5709849A (en) Suppressing stickiness to skin of cosmetic composition
US20070280974A1 (en) Temperature Sensitive State-Changing Hydrogel Composition and Method for Their Preparation
US20070003502A1 (en) Skin preparation for external use characterized by containing sugar derivative of alpha, alpha-trehalose
US4999348A (en) Liquid crystal containing cosmetic and pharmaceutical compositions and methods for utilizing such compositions
EP1189579B1 (en) Gelled aqueous cosmetic compositions
EP0875244A2 (en) Cosmetically accceptable microstructured compositions
WO2007077399A2 (en) Dermatological viscoelastic gel
JP2003048846A (en) Collagenase inhibitor and antiaging cosmetic
US6287543B1 (en) Composition especially in the form of emulsion, gel or aqueous solution, including a crosslinked poly (2-acrylamido-2-methylpropanesulphonic acid) polymer neutralized to at least 90%
WO1999059537A1 (en) Cosmetic preparations in the form of a stick
US6277388B1 (en) Stable gelled aqueous composition with a high electrolyte content
JP2002128651A (en) Photoaging inhibitor and skin care preparation characterized by comprising the same
US20020048603A1 (en) Hydrogel composition
WO2007114262A1 (en) Casein nanoparticle
JP2000273033A (en) Gel comprising natural material
JP2001342451A (en) Method for manufacturing thickener and cosmetic
JPH1045546A (en) Hair-dressing agent
JP2005060234A (en) External preparation for skin
JP2001199872A (en) Additive for ceramide formulated cosmetic and cosmetic
JP2003048812A (en) Elastase inhibitor and antiaging cosmetic
US7456147B2 (en) Controlled release of active agents utilizing repeat sequence protein polymers
JP2002255827A (en) Skin care preparation

Legal Events

Date Code Title Description
AS Assignment

Owner name: SHISEIDO COMPANY, LTD., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MIYAZAWA, KAZUYUKI;KANEDA, ISAMU;YANAKI, TOSHIO;AND OTHERS;REEL/FRAME:012324/0343;SIGNING DATES FROM 20010907 TO 20010921